专利摘要:
Hochaktives Pankreatin gewinnt man durch Autolyse eines mit vorzugsweise Natriumhydrogencarbonat gepufferten wäßrigen isopropanolhaltigen Gewebebreies bis zum positiven Ausfall einer Testfällung mittels wäßrigem Isopropylalkohol und Fällung mit steigender Konzentration an Isopropylalkohol, wobei eine Fasersuspension entsteht, die abgesiebt werden kann und aus der Lösung die unmittelbare Gewinnung von Pankreatin durch weitere Erhöhung der Konzentration an Isopropylalkohol erlaubt. Hohes Schüttgewicht des fertigen, trockenen Präparats erzielt man, indem man das ausgefällte Pankreatin durch Aufrühren mit Isopropylalkohol oder Aceton auf eine Konzentration zwischen 70 und 85 % an Isopropanol bzw. 80 bis 95 % an Aceton bringt, absaugt oder abschleudert und unter Behandlung mittrockener Luft oder Stickstoff trocknet.
公开号:SU1644712A3
申请号:SU833682185
申请日:1983-12-29
公开日:1991-04-23
发明作者:Шультце Ханс
申请人:Нордмарк-Верке Гмбх (Фирма);
IPC主号:
专利说明:

The invention relates to medicine, in particular to methods for the preparation of drugs.
The aim of the invention is to increase the yield of the target product with a higher activity.
Example 1 100 kg of pork pancreas frozen at low temperature, passed through a wolf machine or through a cutting board, are mixed in a 250-liter reactor with a solution of 100 g calcium gluconate in 20 l water together with 200 g silicone anti-foam preparation. Depending on the free trypsin content
in the glands, up to 1 kg of the prepared pancreatin dissolved in 5 liters of water is added as an aid to the start of the process. This amount of pancreatin is established by 37 ° hydrolysis test. For this purpose, 120 g of starting material is taken from the loaded batch. After adding 15 liters of 84% isopropyl alcohol, knead a solution of 1.3 kg of sodium bicarbonate in 20 liters of water. They are set to stand overnight, with the temperature increasing from about 2 to 12 ° C, the next morning being warmed to 20 ° C and stirring is continued at this temperature.
sj
Etank yu
s
A notion of the endolysis of an autolysis is recognized by a breakdown for precipitation. For this purpose, during the last autolysis period, first every half hour, then after 15 minutes, 10 g of suspension is taken, stirred for 1 minute with 5.4 ml of 84% isopropyl alcohol using a glass rod the solution is separated from the fibers adhering to the glass rod and kneaded in 20 ml of a 50% magnetically stirred mixer with a magnetic stirrer, 84% aqueous solution of isopropyl alcohol | After a minute, stop the stirrer and leave to precipitate. no pr approximately 3 minutes.
If the sample is positive, autolysis (the presence of a more or less transparent layer 3 mm high after 1 min or 10 mm after 3 min) is completed.
As an example, a series of deposition tests are reproduced, which are used as soon as the autolysate temperature reaches 20 ° C. "
The deposition test data is given in Table. one.
From this example, it can be seen that the most favorable point in time for termination of autolysis occurs in 3 hours. In order to be able to achieve comparable ratios when using unknown (for example, preserved for a shorter or longer time) preparations of the pork pancreas, ZU0 is being tested for hydrolysis. 120 g are taken from the pasty mass of glands mixed with calcium gluconate, mixed with 1.5 g sodium bicarbonate in 25 ml of water and stirred for 30 minutes at 37 ° C. With the breakdown of this accelerated autolysate, a precipitation test is performed. Free trypsin (in the form of pancreatin) in the following amounts is added to the bulk of the loaded material: less than 2 mm / 3 min - 7. mln. E, up to 12 mm / 1 min - 1 mln. greater free sedimentation rate is not added (1 million units of free trypsin is contained, for example, in 250 g of the pancreas, with 4000 units in I g). In this way, it is possible to standardize for practical production conditions raw materials of different origins.
After determining the most favorable point in time, the autolysis of the loaded batch is completed by pumping 72.5 liters of 84% (regenerated) isopropyl alcohol. Stir for 1/2 hour, forming a clear solution containing insoluble fibers, which are separated by sieving. To do this, the contents of the reactor are lowered into an open boiler of 50 liters with a laid sieve having cells of about 5 mm. The boiler is equipped with a root stirrer. The drain pipe of the boiler, equipped with a sieve, is connected by means of a pump with a 500-liter container of polypropylene. 313 l of 84% isopropyl alcohol is loaded into this container, and a descent solution, passed through a Fiber sieve left in the sieve boiler, is now added with slow stirring for another 10 minutes, with the fibers becoming relatively dry. The weight of the fibers is 7-8 kg.
Pancreatin is placed in a 500-liter tank as a coarse sediment for 1 hour in a volume of 80 liters (at 20 ° C; at 24 ° C for 1/2 hour. The sediment is drained and siphoned and sent for regeneration to distillation. on the bottom, mix with 63 liters of regenerated 84% isopropyl alcohol and leave overnight for additional precipitation. The next day, repeat the process, mix the bottom precipitate thus obtained with about 45 liters of 84% isopropyl alcohol, t „e. with so much more than necessary l preparation of pancreatin suspension in 84% strength vom isopropyl alcohol. The suspension was filtered on a 40 cm diameter Nooch-filter and sucked to good drying of
The dense mass pressed on the filter is quickly ground in a cutting machine and spread on a metal sheet. Dried overnight at a heating temperature of up to 55 ° C under a vacuum of approximately 5 mbar
The output of Pancreatin kg 11.6
Amylase activity
P1P E / mg93,6
Lipase activity
P1P E / mg90.3
Protease activity,
FiP E / Mr:
5.6 5.6
activated enterokinase without activating trypsin activity, FiP E / Mr:
 activated with high-kinase4,2
without activating 4.1
The activity of chymotrypsin, PR E / mg:
enterokinase activated 23,3
without activation 28.3
Dry matter content
dogma,% 98,7
Fat content,% 0.4
Bulk density, g / ml 0.65 Density, g / ml 0.76
The number of microorganisms
on 1 g200
Larmakopisi C iA 17th edition (USP HUL) is undesirable.
Examples 2-4. Proceed analogously to example 1, changing the conditions of the process (pH, isopropanol content, autolytic temperature or isopropanol content during interruption or temperature and isopropanol content during precipitation / washing). There is no difference in the yield of pancreatin, if the deposition test varies in each case within the range of 3 to 10 mm / min. | These conditions were tested for each example separately ,,
The test results are shown in Table. 2 o
Example 5. The procedure is the same as in Example 1, but without the addition of isopropanol, the end of autolysis is reached in 2.5 hours. Amylase activity is 83% with a load loss of 5% and lipase activity is 80% with a load loss of 15%.
PRI me R 6. Proceed as in Example 1, adding 5 liters of propanol. At the same time, they reach the end of autolysis in 2.75 hours. Amylase activity is 88% with a load loss of about 5%, and lipase is 88% with a load loss of 10%.
Example 7. Proceed as in Example 1, but 10 L of isopropanol is added. The end of autolysis is reached after 3 hours. Amylase activity is 93% (load loss 5%) and lipase 88% (load loss I%).
j
50
0
,
Q
,
five
II p and me 8 “If you proceed in the same way as in example 1 and raise the temperature to 25 ° C and then interrupt the reaction, the results achieved will be the same as at the temperature
Examples 9 - 12 o Autolysis and precipitation of a mixture of enzymes from an aqueous autolysate are carried out as described in Example 1. To determine the effect of isopropyl alcohol concentration on the washing process, isopropyl alcohol of different concentrations is added to the samples of the pancreatin suspension. sediment resulting from siphoning from the outermost liquid layer; 1 liter of sediment corresponds to approximately 200 g of dry pancreatin. 1 liter of isopropyl alcohol is added to each sample. Different concentrations are obtained by diluting absolute isopropyl alcohol. The dense filter cake, obtained as described in Example 1 by double washing and suction with suction, is dried as described in Example 1, after which its activity and bulk density are determined. When using only 65% isopropyl alcohol, a slight decrease in activity is observed. Despite this, the quality of the resulting product is higher than the quality of the well-known products. The bulk density of the product decreases with increasing concentrations of isopropyl alcohol.
The results are shown in Table. 3
Data comparing the stability of amylase and lipase in pancreatin prepared according to the known and proposed methods are presented in Table 4.
Table 4 shows that in Pancreatin, obtained by known methods, the loss during exercise increases significantly with increasing activity. As for pancreatin, produced by the proposed method, despite the significantly high enzyme activity, it differs at the load with the least loss.
权利要求:
Claims (1)
[1]
Invention Formula
The method of obtaining pancreatin from the pancreas by conducting autolysis at room temperature,
mixing with an organic solvent, removing the precipitate by filtration, washing it with an organic solvent and drying, characterized in that, in order to increase the yield of the desired product with higher activity, autolysis is carried out in a reactor at a pH of 6.5-8.5 and temperature (- 2) - (+ 30) C, while simultaneously analyzing a sample taken from the reactor for precipitation in 55-65% aqueous isopropyl alcohol and, as soon as the sample reaches the sedimentation rate of precipitated autoolysis 3-10 mm for 1-3 min, stop autolysis in the reactor by m adding isopropyl alcohol to a final concentration of 30-35%, then after filtration isopropyl alcohol is again added to the resulting solution to a concentration of 55-65% at 20-24 ° C, the resulting precipitate is washed with 75-95%
isopropyl alcohol, and the drying is carried out in a nitrogen atmosphere at a pressure of 5 mbar.
iTable1
Test mm / min
1030
1030
O-2
O-2
2015
2015
Example
T 9 T 10 T 11 |
65
75
Bulk weight
g / 100 ml 5,3 5,6 5,5 5,6
Table 2
waiting
Rinsing + + drying,
Lh j
С% С5Н7ОН
30 30 10 10 15 15
65 65 55 55 60 60
Yield (amylase)
88 85 91 89 94 91
Table3
12
85
95
Table4
类似技术:
公开号 | 公开日 | 专利标题
SU1644712A3|1991-04-23|Method for preparation of pancreatine from pancreas
AU666531B2|1996-02-15|Processes for the preparation of amylase inhibitor
CN101974589A|2011-02-16|Method for preparing immunocompetent soybean peptide by enzymolysis and membrane separation
EP0046915B1|1984-10-31|A method for the recovery of a peptide-containing compound, and an apparatus for the realization of the method
WO1994024272A1|1994-10-27|Process for purifying collagenase
EP0194877B2|1998-01-28|Purification of cellulose ethers
RU2088112C1|1997-08-27|Method of preparing the primary beet pectin
CN1020734C|1993-05-19|Method for extracting superoxide-dismutase
CN104758919B|2018-03-02|A kind of calf serum de-protein injection and preparation method thereof
CN109527270A|2019-03-29|Leech specific nutrient induces the extracting method of liquid and natural hirudin
CN110196333B|2020-08-07|Extraction method and application of green scale fish glycoprotein
CN105586330B|2019-04-02|A kind of Halase and preparation method thereof
DK166393B|1993-05-10|PROCEDURE FOR PREPARING Aqueous ORGANIC EXTRACTS WITH A HEPARIN CONTENT OF AT LEAST 120 IU / ML
CN101273125B|2011-05-18|Method for production of enzyme
CN1857717A|2006-11-08|Anticancer peptide extract of blood clam and its preparing method
CN1723921A|2006-01-25|Extractive of clam glycopeptide, and its prepn. method
CN107177459A|2017-09-19|A kind of earthworm polypeptide wine and preparation method thereof
SU899611A1|1982-01-23|Process for producing pearl paste from fish scale
JP2002105092A|2002-04-10|Liquid yeast activating substance, solid yeast activating substance, method for producing the same and method for producing fermentation product
SU1404513A1|1988-06-23|Method of producing ovomucoid
EP0083656A1|1983-07-20|Process for preparing a compressed yeast product.
RU2039819C1|1995-07-20|Method for production of collagenase
CN105295072B|2018-04-13|The modification hydrogel of pineapple bran fibre grafting soybean protein and its preparation method and application
CN1176203C|2004-11-17|Method of extracting wine clarificant from marine organism and its application
RU2021352C1|1994-10-15|Method of preparing of additive for concrete mixture
同族专利:
公开号 | 公开日
EP0115023A2|1984-08-08|
UA5996A1|1994-12-29|
ES8407516A1|1984-09-16|
HU196435B|1988-11-28|
DK605583D0|1983-12-29|
YU252483A|1986-10-31|
US4623624A|1986-11-18|
MD411C2|1996-06-30|
CA1208580A|1986-07-29|
YU45584B|1992-07-20|
ES528537A0|1984-09-16|
EP0115023A3|1986-04-09|
EP0115023B1|1988-07-27|
PL245381A1|1984-10-22|
DD212981A5|1984-08-29|
PL141118B1|1987-06-30|
BR8307280A|1984-08-07|
DK173599B1|2001-04-23|
DE3377506D1|1988-09-01|
DK605583A|1984-07-01|
AR232000A1|1985-04-30|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

GB928654A|1960-10-25|1963-06-12|Philips Nv|Improvements in or relating to the production of pancreatin|
GB1328202A|1969-06-17|1973-08-30|Union International Co Ltd|Manufacture of pancreatin|
DE2106706B2|1971-02-12|1973-05-10|Wilson Pharmaceutical & Chemical Corp., Chicago, 111. |METHOD FOR MANUFACTURING PANCREATIN AS A DRY POWDER WITH HIGH PROTEOLYTIC, AMYLOLYTIC AND LIPOLYTIC ACTIVITY|
MX4738E|1976-05-07|1982-08-25|Nattermann A & Cie|PROCEDURE FOR MANUFACTURING ENZYMATIC PREPARATIONS RICH IN LIPASE|
DE2620289C2|1976-05-07|1982-05-19|A. Nattermann & Cie GmbH, 5000 Köln|Production of a lipase-rich enzyme preparation|PH30058A|1989-11-24|1996-11-08|Biochemie Gmbh|Pancreation preparations|
US5861291A|1997-02-24|1999-01-19|Biozymes Inc.|Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof|
US6632429B1|1999-12-17|2003-10-14|Joan M. Fallon|Methods for treating pervasive development disorders|
KR100367659B1|2000-05-08|2003-01-14|주식회사 바이넥스|The method of preparing pancreatin by adding selective stabilizers|
US20070053895A1|2000-08-14|2007-03-08|Fallon Joan M|Method of treating and diagnosing parkinsons disease and related dysautonomic disorders|
IT1319655B1|2000-11-15|2003-10-23|Eurand Int|PANCREATIC ENZYME MICROSPHERES WITH HIGH STABILITY AND RELATIVE PREPARATION METHOD.|
US8030002B2|2000-11-16|2011-10-04|Curemark Llc|Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions|
CA2419572A1|2003-02-18|2004-08-18|Axcan Pharma Inc.|High dosage protease formulation|
CN1809753B|2003-07-29|2010-10-20|索尔瓦药物有限公司|Method for analyzing mixture including physically acceptable pancreatin by two-dimensional gel electrophoresis|
BRPI0509148B8|2004-03-22|2021-05-25|Abbott Products Gmbh|oral pharmaceutical compositions of products containing lipase, in particular pancreatin containing surfactants, their uses and respective manufacturing processes|
US7153504B2|2004-07-30|2006-12-26|Can Technologies, Inc.|Stabilized pancreas product|
WO2006121803A1|2005-05-05|2006-11-16|Sensient Flavors Inc.|Production of beta-glucans and mannans|
AU2006274835B2|2005-07-29|2012-05-24|Abbott Laboratories Gmbh|Processes for the manufacture of sterilized pancreatin powder|
US9198871B2|2005-08-15|2015-12-01|Abbott Products Gmbh|Delayed release pancreatin compositions|
US11266607B2|2005-08-15|2022-03-08|AbbVie Pharmaceuticals GmbH|Process for the manufacture and use of pancreatin micropellet cores|
US20080058282A1|2005-08-30|2008-03-06|Fallon Joan M|Use of lactulose in the treatment of autism|
TW200745337A|2006-02-24|2007-12-16|Aminotech As|Modified process|
US10072256B2|2006-05-22|2018-09-11|Abbott Products Gmbh|Process for separating and determining the viral load in a pancreatin sample|
BRPI0807718B1|2007-02-20|2021-08-10|Aptalis Pharma Limited|COMPOSITION INCLUDING STABLE DIGESTIVE ENZYME, USE OF THE SAME, DOSAGE FORM, PACKAGING AND PREPARATION PROCESS OF A PANCRELIPASE COMPOSITION|
US20090130063A1|2007-11-15|2009-05-21|Solvay Pharmaceuticals Gmbh|Process for separating and determining the viral load in a pancreatin sample|
US10087493B2|2008-03-07|2018-10-02|Aptalis Pharma Canada Ulc|Method for detecting infectious parvovirus in pharmaceutical preparations|
US8658163B2|2008-03-13|2014-02-25|Curemark Llc|Compositions and use thereof for treating symptoms of preeclampsia|
US8084025B2|2008-04-18|2011-12-27|Curemark Llc|Method for the treatment of the symptoms of drug and alcohol addiction|
US9320780B2|2008-06-26|2016-04-26|Curemark Llc|Methods and compositions for the treatment of symptoms of Williams Syndrome|
US11016104B2|2008-07-01|2021-05-25|Curemark, Llc|Methods and compositions for the treatment of symptoms of neurological and mental health disorders|
US10776453B2|2008-08-04|2020-09-15|Galenagen, Llc|Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain|
EP2165717A1|2008-08-27|2010-03-24|Nordmark Arzneimittel GmbH & Co.KG|Method for reducing viral and microbial load on biological extracts containing solids|
US20100092447A1|2008-10-03|2010-04-15|Fallon Joan M|Methods and compositions for the treatment of symptoms of prion diseases|
US9107419B2|2009-01-06|2015-08-18|Curelon Llc|Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces|
NZ593823A|2009-01-06|2013-09-27|Curelon Llc|Compositions and methods for the treatment or the prevention of infections by e. coli|
US9056050B2|2009-04-13|2015-06-16|Curemark Llc|Enzyme delivery systems and methods of preparation and use|
WO2011050135A1|2009-10-21|2011-04-28|Curemark Llc|Methods and compositions for the prevention and treatment of influenza|
CN106310242B|2011-04-21|2020-02-28|柯尔马克有限责任公司|Compounds for the treatment of neuropsychiatric disorders|
ES2558756T3|2011-08-08|2016-02-08|Aptalis Pharma Limited|Method for dissolution test of solid compositions containing digestive enzymes|
US10350278B2|2012-05-30|2019-07-16|Curemark, Llc|Methods of treating Celiac disease|
US10184121B2|2013-06-28|2019-01-22|Allergan Pharmaceuticals International Limited|Methods for removing viral contaminants from pancreatic extracts|
AU2014304176A1|2013-07-22|2016-02-11|Aptalis Pharma Ltd.|High potency pancreatin pharmaceutical compositions|
RU2679832C2|2013-08-09|2019-02-13|Аллерган Фармасьютикалз Интернэйшнл Лимитед|Digestive enzyme composition suitable for enteral administration|
EP3003360B1|2013-11-05|2020-10-07|Allergan Pharmaceuticals International Limited|High potency pancreatin pharmaceutical compositions|
CN107073084A|2014-11-05|2017-08-18|雅培制药股份有限公司|Method for producing the composition with lipase active and the composition suitable for medicinal usage with improved security feature|
CN109475610A|2016-03-28|2019-03-15|雅培制药股份有限公司|The enzymatic compositions of virus and microbial contamination reduction|
EP3688153A1|2017-09-27|2020-08-05|Abbott Laboratories GmbH|Enzyme compositions with reduced viral and microbial contamination|
CN108316036A|2018-01-25|2018-07-24|陕西科技大学|A kind of method that bean dregs prepare fento cellulose|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
DE19823248588|DE3248588A1|1982-12-30|1982-12-30|Process for obtaining pancreatin with high apparent density|
DE19823248587|DE3248587A1|1982-12-30|1982-12-30|Process for obtaining pancreatin|
[返回顶部]